Cargando…
Modeling the dynamics of antibody–target binding in living tumors
Antibodies have become an attractive class of therapeutic agents for solid tumors, mainly because of their high target selectivity and affinity. The target binding properties of antibodies are critical for their efficacy and toxicity. Our lab has developed a bioluminescence resonance energy transfer...
Autores principales: | Tang, Yu, Cao, Yanguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542163/ https://www.ncbi.nlm.nih.gov/pubmed/33028895 http://dx.doi.org/10.1038/s41598-020-73711-y |
Ejemplares similares
-
Physiological Considerations for Modeling in vivo Antibody-Target Interactions
por: Dunlap, Tyler, et al.
Publicado: (2022) -
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
por: Tang, Yu, et al.
Publicado: (2021) -
A Physiologically Based Pharmacokinetic Framework for Quantifying Antibody Distribution Gradients from Tumors to Tumor-Draining Lymph Nodes
por: Salgado, Eric, et al.
Publicado: (2022) -
A Bioluminescence Resonance Energy Transfer-Based Approach for Determining Antibody-Receptor Occupancy In Vivo
por: Tang, Yu, et al.
Publicado: (2019) -
Experimental Data and PBPK Modeling Quantify Antibody Interference in PEGylated Drug Carrier Delivery
por: Talkington, Anne M., et al.
Publicado: (2021)